Mucopolysaccharidosis I (MPS I) Registry
Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
Psoriasis Longitudinal Assessment and Registry
Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malign
Cetuximab and/or Dasatinib in Treating Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ABLATE AF Registry Trial
A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheuma
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicine.
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
Multi-Institutional Registry for Prostate Cancer Radiosurgery
S0820, Adenoma and Second Primary Prevention Trial
A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
AMG 151 Amgen Protocol Number 20100761
Sofia Strep A FIA Field Study
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Parkinson's Foundation Quality Improvement Initiative
Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy
A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)
CNDO-109-AANK for AML in First Complete Remission (CR1)
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Study to Evaluate Coconut Oil for Alzheimer's Disease
Sickle Cell Trait in Football Players
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
Prospective Study on Cesarean Wound Outcomes
A Safety Study of SGN-LIV1A in Breast Cancer Patients
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment
Dabrafenib, Trametinib, and Navitoclax in Treating Patients With BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surg
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Study of Trametinib in Advanced Cancer Patients With Hepatic Dysfunction
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Di
Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screeni
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST
Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
Testosterone Plus Finasteride Treatment After Spinal Cord Injury
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid Tumors
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
Treatments Against RA and Effect on FDG-PET/CT
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastati
A Study of BGB324 in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Scr
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
BBD Longitudinal Study of Osteogenesis Imperfecta
Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patient
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangeme
Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma
CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Vasculitis Pregnancy Registry
Study to Evaluate Imetelstat (GRN163L) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Synd
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Co
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer
Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Can
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
Optimal Treatment for Recurrent Clostridium Difficile
Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors
Validation Study on the Impact of Decipher® Testing - VANDAAM Study
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
The National Myelodysplastic Syndromes (MDS) Study
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Trea
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
A Study of H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia
Olaparib With or Without Atezolizumab in Treating Patients With Locally Advanced Unresectable or Metastatic Non-HER2-Positive Breast Cancer
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Phase 3 Alogliptin Pediatric Study
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Su
Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery
Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors
A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
Delineating Swallowing Impairment and Decline in ALS
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repai
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
A Pivotal Study of the Premia Spine TOPS™ System
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With BCG Unresponsive
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation,
DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
MAGE-A4ᶜ¹º³²T for Multi-Tumor
Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
Spanish Intervention for Caregivers of Veterans With Stroke
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implanta
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN)
Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology
A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus
Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas
Study Evaluating Safety and Efficacy of UCART123 in Patients With Relapsed/ Refractory Acute Myeloid Leukemia
A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Wi
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Impact of Neuropsychological Evaluation on Epilepsy Treatment
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma
Transfusion Trigger After Operations in High Cardiac Risk Patients
Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma
Prosthetic Smart Socket Technology to Improve Patient Interaction, Usability, Comfort, Fit, and Function.
Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regimens of Olokizumab (OKZ), in Subjects With Rheumatoid Arthritis (RA) W
Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMT CTN 1507)
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remi
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Adjuvant Avelumab in Merkel Cell Cancer
Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistul
Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors
A Study of ONO-7475 in Patients With Acute Leukemias
Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment
Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer
A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractor
Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b
Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
Continuous Monitoring and Control of Hypoglycemia
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately R
Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)
Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Col
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine
IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
Long Term Follow-Up of Subjects Exposed to GSK3377794
A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With M
A Study of XmAb®18087 in Subjects With NET and GIST
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic or Inoperable Locally Ad
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Solid Tumors
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
FA Clinical Outcome Measures
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
The PREDICT Registry for DCIS Patients With DCISionRT Testing
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
Benefits of µCor in Ambulatory Decompensated Heart Failure
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer Th
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic O
PRISM Study-Pruritus Relief Through Itch Scratch Modulation
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
ECG Belt for CRT Response